Clinical Trials Browser

Adenocarcinoma of Lung × pembrolizumab × 30 days × Clear all

NCT05566223 2026-02-23

CheckCell-2

Phase 1/2 Withdrawn

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung